MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.

NCT02616250 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Rosacea

Interventions

DRUG: Brimonidine 0.33% gel (Br)
OTHER: CD07805/47 (Br) placebo gel
DRUG: Ivermectin 1% cream (IVM)
OTHER: CD5024 (IVM) placebo cream

Sponsor

Galderma R&D